Literature DB >> 31322912

Acetylcholine-producing T cells augment innate immune-driven colitis but are redundant in T cell-driven colitis.

Rose A Willemze1, David J Brinkman1,2, Olaf Welting1, Patricia H P van Hamersveld1, Caroline Verseijden1, Misha D Luyer2, Manon E Wildenberg1, Jurgen Seppen1, Wouter J de Jonge1,3.   

Abstract

Clinical trials suggest that vagus nerve stimulation presents an alternative approach to classical immune suppression in Crohn's disease. T cells capable of producing acetylcholine (ChAT+ T cells) in the spleen are essential mediators of the anti-inflammatory effect of vagus nerve stimulation. Besides the spleen, ChAT+ T cells are found abundantly in Peyer's patches of the small intestine. However, the role of ChAT+ T cells in colitis pathogenesis is unknown. Here, we made use of CD4creChATfl/fl mice (CD4ChAT-/- mice) lacking ChAT expression specifically in CD4+ T cells. Littermates (ChATfl/fl mice) served as controls. In acute dextran sulfate sodium (DSS)-induced colitis (7 days of 2% DSS in drinking water), CD4ChAT-/- mice showed attenuated colitis and lower intestinal inflammatory cytokine levels compared with ChATfl/fl mice. In contrast, in a resolution model of DSS-induced colitis (5 days of 2% DSS followed by 7 days without DSS), CD4ChAT-/- mice demonstrated a worsened colitis recovery and augmented colonic histological inflammation scores and inflammatory cytokine levels as compared with ChATfl/fl mice. In a transfer colitis model using CD4+CD45RBhigh T cells, T cells from CD4ChAT-/- mice induced a similar level of colitis compared with ChATfl/fl T cells. Together, our results indicate that ChAT+ T cells aggravate the acute innate immune response upon mucosal barrier disruption in an acute DSS-induced colitis model, whereas they are supporting the later resolution process of this innate immune-driven colitis. Surprisingly, ChAT expression in T cells seems redundant in the context of T cell-driven colitis.NEW & NOTEWORTHY By using different mouse models of experimental colitis, we provide evidence that in dextran sulfate sodium-induced colitis, ChAT+ T cells capable of producing acetylcholine worsen the acute immune response, whereas they support the later healing phase of this innate immune-driven colitis.

Entities:  

Keywords:  ChAT; T cells; acetylcholine; colitis; intestinal inflammation

Mesh:

Substances:

Year:  2019        PMID: 31322912     DOI: 10.1152/ajpgi.00067.2019

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  6 in total

Review 1.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

2.  Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?

Authors:  Yu-Chen Pai; Linda Chia-Hui Yu
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

Review 3.  Bioelectronics in the brain-gut axis: focus on inflammatory bowel disease (IBD).

Authors:  Nathalie Stakenborg; Guy E Boeckxstaens
Journal:  Int Immunol       Date:  2021-06-07       Impact factor: 4.823

4.  Dietary Curdlan Enhances Bifidobacteria and Reduces Intestinal Inflammation in Mice.

Authors:  Shafaque Rahman; Mark Davids; Patricia H P van Hamersveld; Olaf Welting; Hakim Rahaoui; Frank Schuren; Sybren L Meijer; René M van den Wijngaard; Theodorus B M Hakvoort; Wouter J de Jonge; Sigrid E M Heinsbroek
Journal:  Nutrients       Date:  2021-04-15       Impact factor: 5.717

5.  Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation.

Authors:  April S Caravaca; Yaakov A Levine; Anna Drake; Michael Eberhardson; Peder S Olofsson
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

Review 6.  Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions.

Authors:  Jaciara Fernanda Gomes Gama; Liana Monteiro da Fonseca Cardoso; Rodrigo da Cunha Bisaggio; Jussara Lagrota-Candido; Andrea Henriques-Pons; Luiz A Alves
Journal:  Cells       Date:  2022-07-29       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.